📰 Frederickm Hudson News
Frederickm Hudson News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Frederickm Hudson. Real-time updates on events, politics, business and more.
January 18, 2024
Congress Asset Management Co. MA boosted its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 19.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 917,164 shares of the specialty pharmaceutical company’s stock after buying an additional 147,105 shares during the […]
December 29, 2023
Campbell Newman Asset Management Inc. raised its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 63.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,355 shares of the specialty pharmaceutical company’s stock after purchasing an additional 16,476 shares during the quarter. Campbell […]
December 22, 2023
Legato Capital Management LLC decreased its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,472 shares of the specialty pharmaceutical company’s stock after selling 837 shares during […]
December 10, 2023
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a report released on Wednesday. Separately, Piper Sandler raised their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on Thursday, November 9th. […]
November 28, 2023
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research report released on Saturday. Separately, Piper Sandler increased their target price on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the stock an overweight rating in a report on Thursday, November 9th. […]
November 20, 2023
StockNews.com lowered shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday. Separately, Piper Sandler lifted their price target on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a research report on […]